Detalhe da pesquisa
1.
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer.
Nat Commun
; 15(1): 672, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253555
2.
Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden.
Cancer Cell
; 41(10): 1731-1748.e8, 2023 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774698
3.
Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis.
Cancer Res
; 81(7): 1813-1826, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495232
4.
EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer.
Nat Cancer
; 1(4): 394-409, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33269343